n | % | ||
---|---|---|---|
Age (years) | |||
Median (range) | 58 (18–85) | ||
Karnofsky PS | |||
60% | 4 | 9 | |
70% | 14 | 32 | |
80% | 18 | 41 | |
90% | 8 | 18 | |
Primarius | |||
Uterus | 16 | 36 | |
Ovary | 14 | 32 | |
Cervix | 9 | 21 | |
Vulva | 4 | 9 | |
Fallopian tube | 1 | 2 | |
Histology | |||
Ovaries | 14 | 32 | |
Endometrioid | 5 | 36 | |
Mucinous | 2 | 14 | |
Papillary serous | 2 | 14 | |
Clear cell | 5 | 36 | |
Fallopian tubes | 1 | 2 | |
Adenocarcinoma | 1 | 100 | |
Uterus | 16 | 36 | |
Endometrioid | 2 | 13 | |
Papillary serous | 4 | 25 | |
Clear cell | 3 | 18 | |
Leiomyosarcoma | 7 | 44 | |
Cervix | 9 | 21 | |
Squamous cell | 9 | 100 | |
Vulva | 4 | 9 | |
Squamous cell | 4 | 100 | |
Number of bone metastases | |||
Mean (range) | 2.1 (1–7) | ||
Solitary | 23 | 52 | |
Multiple | 21 | 48 | |
Spine involvment | |||
Thoracic | 15 | 34 | |
Lumbar | 24 | 55 | |
Thoracic and lumbar | 5 | 11 | |
Distant metastases | |||
Brain | 15 | 44 | |
Lung | 20 | 59 | |
Liver | 10 | 29 | |
Skin | 1 | 3 |